BioAdvance, the operator of the Biotechnology Greenhouse of Southeastern Pennsylvania, has expanded its team with the additions of a new venture partner and a new entrepreneur-in-residence.
Dr. Gregory R. Harriman, the venture partner, brings more than 25 years of experience in academic medicine and the biopharmaceutical industry. He previously held research and development posts at IVAX, Centocor and Johnson & Johnson. In 2006, Harriman founded Main Line Ventures, n Berwyn, Pa., investment and consulting company focused on the life sciences industry. He is also a research professor in the School of Biomedical Engineering Science and Health Systems at Drexel University, and a member of Robin Hood Ventures, a Philadelphia angel investing group.
To read the original article: BioAdvance adds venture partner, entrepreneur-in-residence - Philadelphia Business Journal
